Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
1,2- 0,05% <0.05 ≥0,6%
EC/CAS
55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
<0.0015
EC/CAS
220-239-6/2682-20-4
Name of the chemical
2-Methyl-2H-isothiazol-3-one
Concentration
<0.0015
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
<30
EC/CAS
207-439-9
Name of the chemical
Calcium carbonate
Concentration
<70
General Information
Version
4.1
Revision date
2024-10-03
Product name
Fill and Finish
Product Synonyms
Not Available
Chemical name
Not Applicable
1.2.1 Relevant identified uses
Use according to manufacturer"s directions
Icons in SDS
Company Information
company name
Knauf UK & Ireland GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
cservice@knauf.com
GHS Information
Signal word
Not Applicable
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification according to regulation (EC) No Non hazardous
Hazard pictograms
Not Applicable
Signal word
Not Applicable Page 1 continued...
Hazard statements
Not Applicable
Supplemental label elements
Contains mixture of: 5-chloro-2-methyl-2H-isothiazol-3-one [EC no. 247-500-7] and 2-methyl-2H -isothiazol-3-one [EC no. 220- EUH208 239-6] (3:1), 2-methyl-2H-isothiazol-3-one, 1,2-benzisothiazol-3(2H)-one. May produce an allergic reaction. EUH210 Safety data sheet available on request.
Prevention
Not Applicable
Response
Not Applicable
Storage
Not Applicable
Disposal
Not Applicable Material contains calcium carbonate, vinyl acetate homopolymer, 1,2-benzisothiazoline-3-one, isothiazolinones, mixed.
2.3 Other hazards
Ingestion may produce health damage*. Cumulative effects may result following exposure*. Vapours potentially cause drowsiness and dizziness*. 1,2-benzisothiazoline-3- Determined to have endocrine-disrupting properties according to Europe Regulation (EU) 528/2012, Europe Regulation (EU) one 2017/2100, and Europe Regulation (EU) 2018/605
